Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study is designed as a randomized, double blind, parallel group, placebo-controlled trial to study the efficacy and safety of two oral doses of Prurisol administered twice daily for twelve weeks to subjects with moderate to severe chronic plaque psoriasis.
Epistemonikos ID: 5f8cf75addfa1d896cdd8e022d81bc3fbc2a6057
First added on: May 17, 2024